6936 Vetnostrum: Announcement on Waiver of Non-Compete Obligations for New Directors
Vetnostrum (6936) announced that the shareholders' meeting approved the waiver of non-compete restrictions for new directors, including Li Fang-chuan, Chien Chih-wei, and Luo Bao-zhu.
📋 Article Processing Timeline
- 📰 Published: May 23, 2026 at 06:31
- 🔍 Collected: May 23, 2026 at 06:31 (0 min after Published)
- 🤖 AI Analyzed: May 31, 2026 at 21:04 (206h 32m after Collected)
1. Date of shareholders' resolution: 115/05/22. 2. Permitted directors: Li Fang-chuan (Corporate Rep), Chien Chih-wei (Corporate Rep), Luo Bao-zhu (Independent Director). 3. Permitted behavior: Investing in or managing companies with similar business scope. 4. Mainland China business: Li Fang-chuan holds positions at Dequan Pharmaceutical (Jiangsu) and Dezhen Medicine (Jiangsu). 5. Financial impact: No material impact.
FAQ
What is involvement in Mainland China business?
Taiwanese companies must disclose director involvement in businesses located in Mainland China.